Cargando…

The Value of Fetal Heart Evaluation in Fetuses with Rare Congenital Lymphangiomas: A Cohort Study from a Single Tertiary Center across Two Decades (Years 1999–2020)

Lymphangiomas are uncommon, benign (from a histopathology viewpoint) malformations of the lymphatic system with thin-walled vessels; however, these tumors may be dangerous for fetal or neonatal life. They are observed in 1:6000 newborns at birth and in 1:750 spontaneous abortions. We aimed to invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Kordjalik, Paulina, Szmyd, Bartosz, Karuga, Filip Franciszek, Daszkiewicz, Gabriela, Strzelecka, Iwona, Respondek-Liberska, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874571/
https://www.ncbi.nlm.nih.gov/pubmed/35207307
http://dx.doi.org/10.3390/jcm11041035
_version_ 1784657720311283712
author Kordjalik, Paulina
Szmyd, Bartosz
Karuga, Filip Franciszek
Daszkiewicz, Gabriela
Strzelecka, Iwona
Respondek-Liberska, Maria
author_facet Kordjalik, Paulina
Szmyd, Bartosz
Karuga, Filip Franciszek
Daszkiewicz, Gabriela
Strzelecka, Iwona
Respondek-Liberska, Maria
author_sort Kordjalik, Paulina
collection PubMed
description Lymphangiomas are uncommon, benign (from a histopathology viewpoint) malformations of the lymphatic system with thin-walled vessels; however, these tumors may be dangerous for fetal or neonatal life. They are observed in 1:6000 newborns at birth and in 1:750 spontaneous abortions. We aimed to investigate the role of fetal echocardiography in the prognosis of lymphangioma. Selected data of 19,836 pregnant women studied between 1999 and 2020 were retrospectively analyzed. In total, 32 cases of lymphangioma meeting the following criteria were further analyzed: (1) ultrasound availability from the 1st trimester of pregnancy and (2) nuchal translucency ≤ 2.5 mm. Echocardiographic findings, karyotype, size, and location of the possible lesion were juxtaposed with the clinical follow-up. The statistical analysis was performed using Statistica 13.1 software (StatSoft, Tulsa, OK, USA). Lymphangioma in the analyzed material coexisted with abnormalities in fetal echo in 78% (n = 25) of cases, especially: heart defect in 50% (n = 16) and with normal heart structure with functional changes in 28% (n = 9). Karyotype was available in 50% of the analyzed cases (n = 16). Normal cytogenetic results were observed in 62.5% (n = 10) of cases. In the remaining cases, the following were observed: Turner Syndrome: 25% (n = 4) and Down Syndrome 12.5% (n = 2). The rate of alive newborns was significantly higher among fetuses with isolated lymphangioma in comparison to those with lymphangioma associated with abnormal ECHO examination: 38.46% (n = 5) vs. 15.38% (n = 2; p = 0.037). Abnormal ECHO exam was a poor prognostic sign for fetuses with lymphangioma; therefore, we think it is important to refer these cases for detailed echocardiography in tertiary centers. Moreover, it should be highlighted that in all lymphangioma cases there was an indication to perform the karyotype assessment, as there was a high risk of aneuploidy.
format Online
Article
Text
id pubmed-8874571
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88745712022-02-26 The Value of Fetal Heart Evaluation in Fetuses with Rare Congenital Lymphangiomas: A Cohort Study from a Single Tertiary Center across Two Decades (Years 1999–2020) Kordjalik, Paulina Szmyd, Bartosz Karuga, Filip Franciszek Daszkiewicz, Gabriela Strzelecka, Iwona Respondek-Liberska, Maria J Clin Med Article Lymphangiomas are uncommon, benign (from a histopathology viewpoint) malformations of the lymphatic system with thin-walled vessels; however, these tumors may be dangerous for fetal or neonatal life. They are observed in 1:6000 newborns at birth and in 1:750 spontaneous abortions. We aimed to investigate the role of fetal echocardiography in the prognosis of lymphangioma. Selected data of 19,836 pregnant women studied between 1999 and 2020 were retrospectively analyzed. In total, 32 cases of lymphangioma meeting the following criteria were further analyzed: (1) ultrasound availability from the 1st trimester of pregnancy and (2) nuchal translucency ≤ 2.5 mm. Echocardiographic findings, karyotype, size, and location of the possible lesion were juxtaposed with the clinical follow-up. The statistical analysis was performed using Statistica 13.1 software (StatSoft, Tulsa, OK, USA). Lymphangioma in the analyzed material coexisted with abnormalities in fetal echo in 78% (n = 25) of cases, especially: heart defect in 50% (n = 16) and with normal heart structure with functional changes in 28% (n = 9). Karyotype was available in 50% of the analyzed cases (n = 16). Normal cytogenetic results were observed in 62.5% (n = 10) of cases. In the remaining cases, the following were observed: Turner Syndrome: 25% (n = 4) and Down Syndrome 12.5% (n = 2). The rate of alive newborns was significantly higher among fetuses with isolated lymphangioma in comparison to those with lymphangioma associated with abnormal ECHO examination: 38.46% (n = 5) vs. 15.38% (n = 2; p = 0.037). Abnormal ECHO exam was a poor prognostic sign for fetuses with lymphangioma; therefore, we think it is important to refer these cases for detailed echocardiography in tertiary centers. Moreover, it should be highlighted that in all lymphangioma cases there was an indication to perform the karyotype assessment, as there was a high risk of aneuploidy. MDPI 2022-02-16 /pmc/articles/PMC8874571/ /pubmed/35207307 http://dx.doi.org/10.3390/jcm11041035 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kordjalik, Paulina
Szmyd, Bartosz
Karuga, Filip Franciszek
Daszkiewicz, Gabriela
Strzelecka, Iwona
Respondek-Liberska, Maria
The Value of Fetal Heart Evaluation in Fetuses with Rare Congenital Lymphangiomas: A Cohort Study from a Single Tertiary Center across Two Decades (Years 1999–2020)
title The Value of Fetal Heart Evaluation in Fetuses with Rare Congenital Lymphangiomas: A Cohort Study from a Single Tertiary Center across Two Decades (Years 1999–2020)
title_full The Value of Fetal Heart Evaluation in Fetuses with Rare Congenital Lymphangiomas: A Cohort Study from a Single Tertiary Center across Two Decades (Years 1999–2020)
title_fullStr The Value of Fetal Heart Evaluation in Fetuses with Rare Congenital Lymphangiomas: A Cohort Study from a Single Tertiary Center across Two Decades (Years 1999–2020)
title_full_unstemmed The Value of Fetal Heart Evaluation in Fetuses with Rare Congenital Lymphangiomas: A Cohort Study from a Single Tertiary Center across Two Decades (Years 1999–2020)
title_short The Value of Fetal Heart Evaluation in Fetuses with Rare Congenital Lymphangiomas: A Cohort Study from a Single Tertiary Center across Two Decades (Years 1999–2020)
title_sort value of fetal heart evaluation in fetuses with rare congenital lymphangiomas: a cohort study from a single tertiary center across two decades (years 1999–2020)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874571/
https://www.ncbi.nlm.nih.gov/pubmed/35207307
http://dx.doi.org/10.3390/jcm11041035
work_keys_str_mv AT kordjalikpaulina thevalueoffetalheartevaluationinfetuseswithrarecongenitallymphangiomasacohortstudyfromasingletertiarycenteracrosstwodecadesyears19992020
AT szmydbartosz thevalueoffetalheartevaluationinfetuseswithrarecongenitallymphangiomasacohortstudyfromasingletertiarycenteracrosstwodecadesyears19992020
AT karugafilipfranciszek thevalueoffetalheartevaluationinfetuseswithrarecongenitallymphangiomasacohortstudyfromasingletertiarycenteracrosstwodecadesyears19992020
AT daszkiewiczgabriela thevalueoffetalheartevaluationinfetuseswithrarecongenitallymphangiomasacohortstudyfromasingletertiarycenteracrosstwodecadesyears19992020
AT strzeleckaiwona thevalueoffetalheartevaluationinfetuseswithrarecongenitallymphangiomasacohortstudyfromasingletertiarycenteracrosstwodecadesyears19992020
AT respondekliberskamaria thevalueoffetalheartevaluationinfetuseswithrarecongenitallymphangiomasacohortstudyfromasingletertiarycenteracrosstwodecadesyears19992020
AT kordjalikpaulina valueoffetalheartevaluationinfetuseswithrarecongenitallymphangiomasacohortstudyfromasingletertiarycenteracrosstwodecadesyears19992020
AT szmydbartosz valueoffetalheartevaluationinfetuseswithrarecongenitallymphangiomasacohortstudyfromasingletertiarycenteracrosstwodecadesyears19992020
AT karugafilipfranciszek valueoffetalheartevaluationinfetuseswithrarecongenitallymphangiomasacohortstudyfromasingletertiarycenteracrosstwodecadesyears19992020
AT daszkiewiczgabriela valueoffetalheartevaluationinfetuseswithrarecongenitallymphangiomasacohortstudyfromasingletertiarycenteracrosstwodecadesyears19992020
AT strzeleckaiwona valueoffetalheartevaluationinfetuseswithrarecongenitallymphangiomasacohortstudyfromasingletertiarycenteracrosstwodecadesyears19992020
AT respondekliberskamaria valueoffetalheartevaluationinfetuseswithrarecongenitallymphangiomasacohortstudyfromasingletertiarycenteracrosstwodecadesyears19992020